Oakwise Capital Private Product Overview
Value Fund Series
Value Fund Series is an umbrella-structured fund, which mainly invests in secondary market，focusing on fixed income. The Fund exists to offer a range of Sub-Funds with diverse investment strategies to fulfil investors’ different investment needs.
Enhanced Income Series
This series primarily invests in Chinese USD bond , which can provide not only short-term fixed income, but also a higher floating income with leverage. It is an ideal choice of liquidity management or robust asset allocation for professional investors.
China High Yield Income Series
The series aims to achieve medium to long-term capital appreciation by primarily investing in the Greater China region and Asia Pacific high yield fixed income securities.
Multi-Strategy Growth and Income Series
As a commingled series, it invests in bond, equity and pre-IPO projects, providing investors with stable investment returns through decentralized allocation
Stable Growth Series
As a commingled series, it mainly invests in China US dollar corporate bonds and highly selective stocks in new economy industries, so as to obtain outperformed returns for investors
Innovation Fund Series
Innovation Fund Series primarily invests in Private Equity Market. The Fund exists to offer investors a range of Sub-Funds focusing on new-generation IT, Advanced Manufacturing, Consumer & Retail, TMT, Biomedical, New Energy and other industrial leading enterprises in new economy industries, and obtained outstanding investment performance.
Growth Fund Series
Growth Fund Series primarily invests in highly selective stocks with high quality across the globe. With different investment themes, the Fund exists to offer a range of portfolios,
which seek to benefit from their respective industry growth.
Global Technology Select Series
This Series aims to deliver outperformed returns by primarily investing in global leading technology companies and fast-growing technology companies
Global Healthcare Select Series
This Series seeks to benefit from the explosive growth of global healthcare industry by primarily investing in the global healthcare industry leaders and high-growth innovative healthcare companies